Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 a Multi-center Randomized Blinding Clinical Trial Study
Conditions
Interventions
PHR160 Spray
Placebo
+1 more
Locations
1
Iran
Mohammad Sadegh Bagheri Baghdasht
Tehran, Iran
Start Date
August 15, 2020
Primary Completion Date
November 15, 2020
Completion Date
December 15, 2020
Last Updated
November 4, 2020
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
Baqiyatallah Medical Sciences University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions